跳至主要内容
临床试验/JPRN-UMIN000028601
JPRN-UMIN000028601已完成未知

Safety and efficacy of intra-articular injection of platelet rich plasma in patients with ankle osteoarthritis - Platelet-rich Plasma in patients with ankle osteoarthritis

Department of Orthopaedic Surgery, Graduate School of Medicine, Chiba University0 个研究点目标入组 20 人开始时间: 2017年8月10日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

简要总结

o serious adverse effects were observed related with intra-articular injection of platelet rich plasma. The VAS scores significantly decreased from baseline to 4, 12, and 24 weeks after treatment. The JSSF scale score and the pain and pain-related subscale score of the SAFE-Q significantly improved from baseline to 12 weeks after treatment.

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1 Anemia (hemoglobin levels less than 11mg/dl) 2 Thrombocytopenia (platelet levels less than 150*103/ul) 3 History of ankle surgery or ankle fracture within the past 12 months 4 Treatment with steroid or hyaluronic acid injections within the past 6 months 5 Treatment with oral anticoagulant 6 Systemic inflammatory disease (eg rheumatoid arthritis) 7 Renal failure 8 Hepatic failure 9 Diabetes mellitus (HbA1c more than 9.0) 10 Psychological disease 11 Pregnancy 12 Infection of the ankle 13 Cancer or malignant lesions

研究者

发起方
Department of Orthopaedic Surgery, Graduate School of Medicine, Chiba University

相似试验

Safety and efficacy of intra-articular injection of... | 临床试验